PharmaCommunications is pleased to announce the appointment of Ruixue (Snow) Zhao to the position of Manager, Accounting as of Tuesday June 13, 2017. Snow joins PharmaCommunications with extensive experience as an Accountant/Controller. She holds a Bachelor of Computer Engineering degree from ZhengZhou University, China, a B.Comm. in Accountancy from Concordia University, Montreal, as well as CPA and CGA Designations. Snow will report to our COO, Nicole Archambault.
PharmaCommunications is pleased to announce the appointment of Anneisa Ali as Manager, Implementation as of Monday April 10, 2017. Anneisa joins PharmaCommunications with over 13 years of experience as a Manager and Senior Manager in Client Services, Account Management, Training, and Relationship Management with both Canadian healthcare companies, and multinational data and software firms. She holds a B.Sc. in Biology from the University of Toronto, and will report to our CEO, Ron Maheu.
PharmaCommunications is pleased to announce the appointment of Francine Vossah to the position of Director, Corporate Quality. Previously the Manager, Quality she contributed to not only the organizations quality mandate but has also led the successful implementation of several special projects. In her new role, Francine will lead the internal regulatory compliance and quality initiatives and now holds a position with the organization’s executive management team.
PharmaCommunications is pleased to announce the appointment of Ashley Rycroft to the position of Vice-President, Sales & Marketing. Ashley joined PharmaCommunications in October 2009 as Manager of Client Services, and in April 2011 was promoted to Director of Client Services. In her time with the company, Ashley has built a solid account and support team to service our clients, and has personally spearheaded many of our business development initiatives. In her new role as Vice-President, she will not only continue to coordinate these activities, but will play an ever increasing role in the executive management of the company.
Check back regularly for the latest news from PharmaCommunications.